本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

24.76
+0.60502.51%
成交量:30.40万
成交额:756.68万
市值:33.19亿
市盈率:-13.84
高:25.30
开:24.52
低:24.43
收:24.15
52周最高:25.30
52周最低:9.60
股本:1.34亿
流通股本:8,495.06万
量比:1.99
换手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):-1.7885
每股收益(LYR):-2.0595
净资产收益率:-72.92%
总资产收益率:-28.96%
市净率:9.62
市盈率(LYR):-12.02

数据加载中...

2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities